| Acquisition Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI (LODR) Regulations, 2015) and in furtherance of our letter dated 29th December, 2022 regarding the execution of a definitive agreement by the Company for acquiring 8,57,65,631 equity shares representing 76% of the total paid-up equity share capital (fully diluted basis) of DR Axion India Private Limited, we wish to inform you that the Company has completed the acquisition of the 76% equity stake in DR Axion India Private Limited on 1st February, 2023. | 02/Feb/2023 |
| Acquisition Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI (LODR) Regulations, 2015), we wish to inform you that the Company has entered into a definitive agreement on 29th December, 2022 subject to closing conditions to acquire 8,57,65,631 equity shares representing 76% of the total paid-up equity share capital (fully diluted basis) of DR Axion India Private Limited ( Transaction ). Upon completion of the transaction, DR Axion India Private Limited will be a Subsidiary of the Company. | 30/Dec/2022 |
